Global Infertility Market Charged to grow at the CAGR of 4.52 % from 2015 to 2019
WiseGuyReports.com adds “Global Infertility Market 2015-2019” reports to its Database.
PUNE, INDIA, December 8, 2017 /EINPresswire.com/ --About Infertility 1
Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.
TechNavio's analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.
TechNavio's report, the Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Bayer Healthcare
• CooperSurgical
• Ferring Pharmaceuticals
• Merck & Co.
Other Prominent Vendors
• Abbott Laboratories
• AbbVie
• Actavis
• Apricus Biosciences
• AstraZeneca
• Bristol-Myers Squibb
• Dong-A Socio
• Elelixis Diagnostics
• Eli Lily
• Halotech DNA
• HRA Pharma
• Invo Bioscience
• Medical Electronic Systems
• Novartis
• Pfizer
• PregLem
• Sanofi
• Vivus
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/38467-global-infertility-market-2015-2019
Market Driver
• Increase in Aging Population
• For a full, detailed list, view our report
Market Challenge
• Patent Expires of Major Blockbuster Drugs
• For a full, detailed list, view our report
Market Trend
• Increase in Awareness
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Table of Contents:
Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
07. Country Overview
07.1.1 US
07.1.2 UK
08. Market Landscape
09. Market Segmentation by Type
10. Market Segmentation by Underlying Cause
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Licensing and Collaborations
19.1.3 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Bayer HealthCare
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical Segmentation by Revenue 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 CooperSurgical
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Business Segmentation by Revenue
20.2.5 Business Segmentation by Revenue 2012 and 2013
20.2.6 Business Strategy
20.2.7 Key Developments
20.2.8 SWOT Analysis
20.3 Ferring Pharmaceuticals
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 SWOT Analysis
20.4 Merck & Co. Inc.
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2013
20.4.4 Business Segmentation by Revenue 2012 and 2013
20.4.5 Sales by Geography
20.4.6 Business Strategy
20.4.7 Key Developments
20.4.8 SWOT Analysis
Continued…….
Enquiry Before Buy @ https://www.wiseguyreports.com/enquiry/38467-global-infertility-market-2015-2019
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here
1 https://www.wiseguyreports.com/sample-request/38467-global-infertility-market-2015-2019